These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28695896)

  • 1. R-Spondin chromosome rearrangements drive Wnt-dependent tumour initiation and maintenance in the intestine.
    Han T; Schatoff EM; Murphy C; Zafra MP; Wilkinson JE; Elemento O; Dow LE
    Nat Commun; 2017 Jul; 8():15945. PubMed ID: 28695896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
    Hilkens J; Timmer NC; Boer M; Ikink GJ; Schewe M; Sacchetti A; Koppens MAJ; Song JY; Bakker ERM
    Gut; 2017 Jun; 66(6):1095-1105. PubMed ID: 27511199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma.
    Kawasaki K; Fujii M; Sugimoto S; Ishikawa K; Matano M; Ohta Y; Toshimitsu K; Takahashi S; Hosoe N; Sekine S; Kanai T; Sato T
    Gastroenterology; 2020 Feb; 158(3):638-651.e8. PubMed ID: 31622618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive characterization of RSPO fusions in colorectal traditional serrated adenomas.
    Sekine S; Ogawa R; Hashimoto T; Motohiro K; Yoshida H; Taniguchi H; Saito Y; Yasuhiro O; Ochiai A; Hiraoka N
    Histopathology; 2017 Oct; 71(4):601-609. PubMed ID: 28543708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RSPO fusion transcripts in colorectal cancer in Japanese population.
    Shinmura K; Kahyo T; Kato H; Igarashi H; Matsuura S; Nakamura S; Kurachi K; Nakamura T; Ogawa H; Funai K; Tanahashi M; Niwa H; Sugimura H
    Mol Biol Rep; 2014 Aug; 41(8):5375-84. PubMed ID: 24847761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.
    Picco G; Petti C; Centonze A; Torchiaro E; Crisafulli G; Novara L; Acquaviva A; Bardelli A; Medico E
    EMBO Mol Med; 2017 Mar; 9(3):293-303. PubMed ID: 28100566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function.
    Storm EE; Durinck S; de Sousa e Melo F; Tremayne J; Kljavin N; Tan C; Ye X; Chiu C; Pham T; Hongo JA; Bainbridge T; Firestein R; Blackwood E; Metcalfe C; Stawiski EW; Yauch RL; Wu Y; de Sauvage FJ
    Nature; 2016 Jan; 529(7584):97-100. PubMed ID: 26700806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent R-spondin fusions in colon cancer.
    Seshagiri S; Stawiski EW; Durinck S; Modrusan Z; Storm EE; Conboy CB; Chaudhuri S; Guan Y; Janakiraman V; Jaiswal BS; Guillory J; Ha C; Dijkgraaf GJ; Stinson J; Gnad F; Huntley MA; Degenhardt JD; Haverty PM; Bourgon R; Wang W; Koeppen H; Gentleman R; Starr TK; Zhang Z; Largaespada DA; Wu TD; de Sauvage FJ
    Nature; 2012 Aug; 488(7413):660-4. PubMed ID: 22895193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R-Spondins 2 and 3 Are Overexpressed in a Subset of Human Colon and Breast Cancers.
    Conboy CB; Vélez-Reyes GL; Rathe SK; Abrahante JE; Temiz NA; Burns MB; Harris RS; Starr TK; Largaespada DA
    DNA Cell Biol; 2021 Jan; 40(1):70-79. PubMed ID: 33320737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent PTPRK-RSPO3 fusions and RNF43 mutations in colorectal traditional serrated adenoma.
    Sekine S; Yamashita S; Tanabe T; Hashimoto T; Yoshida H; Taniguchi H; Kojima M; Shinmura K; Saito Y; Hiraoka N; Ushijima T; Ochiai A
    J Pathol; 2016 Jun; 239(2):133-8. PubMed ID: 26924569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential activities and mechanisms of the four R-spondins in potentiating Wnt/β-catenin signaling.
    Park S; Cui J; Yu W; Wu L; Carmon KS; Liu QJ
    J Biol Chem; 2018 Jun; 293(25):9759-9769. PubMed ID: 29752411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EIF3E-RSPO2 and PIEZO1-RSPO2 fusions in colorectal traditional serrated adenoma.
    Hashimoto T; Ogawa R; Yoshida H; Taniguchi H; Kojima M; Saito Y; Sekine S
    Histopathology; 2019 Aug; 75(2):266-273. PubMed ID: 30916365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic roles of Wnt modulators R-spondin2 and R-spondin3 in craniofacial morphogenesis and dental development.
    Alhazmi N; Carroll SH; Kawasaki K; Woronowicz KC; Hallett SA; Macias Trevino C; Li EB; Baron R; Gori F; Yelick PC; Harris MP; Liao EC
    Sci Rep; 2021 Mar; 11(1):5871. PubMed ID: 33712657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer.
    Hashimoto T; Takayanagi D; Yonemaru J; Naka T; Nagashima K; Yatabe Y; Shida D; Hamamoto R; Kleeman SO; Leedham SJ; Maughan T; Takashima A; Shiraishi K; Sekine S
    Br J Cancer; 2022 Oct; 127(6):1043-1050. PubMed ID: 35715628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R-spondin-3 is an oncogenic driver of poorly differentiated invasive breast cancer.
    Ter Steege EJ; Boer M; Timmer NC; Ammerlaan CM; Song JY; Derksen PW; Hilkens J; Bakker ER
    J Pathol; 2022 Nov; 258(3):289-299. PubMed ID: 36106661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of R-spondin proteins in cancer biology.
    Ter Steege EJ; Bakker ERM
    Oncogene; 2021 Nov; 40(47):6469-6478. PubMed ID: 34663878
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Greicius G; Kabiri Z; Sigmundsson K; Liang C; Bunte R; Singh MK; Virshup DM
    Proc Natl Acad Sci U S A; 2018 Apr; 115(14):E3173-E3181. PubMed ID: 29559533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations.
    Fischer MM; Yeung VP; Cattaruzza F; Hussein R; Yen WC; Murriel C; Evans JW; O'Young G; Brunner AL; Wang M; Cain J; Cancilla B; Kapoun A; Hoey T
    Sci Rep; 2017 Nov; 7(1):15270. PubMed ID: 29127379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A WNT/beta-catenin signaling activator, R-spondin, plays positive regulatory roles during skeletal myogenesis.
    Han XH; Jin YR; Seto M; Yoon JK
    J Biol Chem; 2011 Mar; 286(12):10649-59. PubMed ID: 21252233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the follistatin gene by RSPO-LGR4 signaling via activation of the WNT/β-catenin pathway in skeletal myogenesis.
    Han XH; Jin YR; Tan L; Kosciuk T; Lee JS; Yoon JK
    Mol Cell Biol; 2014 Feb; 34(4):752-64. PubMed ID: 24344199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.